Primary Total: $52,502,661
Total: $42,538,086
Primary Total: $39,077,134
Total: $308,824
Primary Total: $187,691
*SWOG-9217, Chemoprevention of Prostate Cancer with Finasteride (Proscar) Phase III, (427583), Southwest Oncology Group, $111,835 (adjustment).
Characterization of Apoptosis-Specific Genes in Prostate Carcinoma Cells, (428609), Council for Tobacco Research, $35,000 (adjustment).
Apoptosis Specific Genes in Prostate Carcinoma Cells, (429471), Natl Cancer Institute, $152,691.
*Phase II Trial of Murine Monoclonal Antibody MEDI-500 (T10B9) in the Treatment of Acute Renal Allograft Rejection Single Daily Dose: Part A, (429836), MedImmune Inc, $9,298.
For questions regarding listings, contact Ms. Deborah Davis, director of the Office of Sponsored Projects Administration, 214 Kinkead Hall, 0057, phone 257-8311. (ddavis@pop.uky.edu )
Last Updated: 6/30/03